Clinical Outcome of Gynaecomastia Surgery Cases—An Eight-Years Retrospective Study ()
1. Introduction
Gynaecomastia is defined as a benign female-like enlargement of the male breast resulting from an increase in ductal tissue, stroma and/or fat [1].
The pathophysiological mechanisms that can lead to gynaecomastia can be either an increase of estrogens, a decrease of androgens, an altered serum androgen to estrogen ratio or androgen receptor defects [2]. Many classifications are described to grade the level of gynecomastia clinically. One of the most commonly used classifications is that made by Simon who classified gynaecomastia into three grades according to the breast size enlargement and the presence or absence of excess skin. In grade I, there is a small visible breast enlargement with no excess skin. Grade II was further subdivided into A and B according to the skin situation where grade IIA had moderate breast enlargement without excess skin while grade IIB had moderate breast enlargement with excess skin. Grade III is a situation in which there is severe breast enlargement with marked skin redundancy (pendulous female breast) [3]. We used this classification in our study.
The main objective of our study was to document the sociodemographic profile of patients presenting with gynecomastia and their subsequent surgical outcomes at a tertiary care hospital, Abu Dhabi, United Arab Emirates over 8 years.
2. Patients and Methods
This is an 8-year retrospective study of patients who underwent gynecomastia surgery at Zayed Military Hospital, a tertiary care center, Abu Dhabi, United Arab Emirates from the period of the beginning of January 2015 till the end of December 2022. The medical records were reviewed and the data were analyzed.
The collected data included demographic data such as age, weight, and body mass index (BMI). Data from history including duration of having the gyanaecomastia, hormonal and protein intake, previous gynaecomastia surgery and smoking were included in the analysis. Clinical examination of the presence of swelling or tenderness bilaterally or unilaterally and the grade of gynaecomastia according to Simon’s classification was assessed. The type of surgery performed, the duration of hospital stay and the development of postoperative complications were also noted in the study.
3. Statistical Analysis
The study employed a chi-square test of independence to investigate the distinction between different types of gynecomastia and the relationship between the kind of operation performed, and the frequency of postoperative complications.
4. Results
A total of 196 patients underwent gynaecomastia surgery during the period from the beginning of January 2015 till the end of December 2022. These patients were referred from either the Family Medicine clinic or from the Endocrinology clinic to the Plastic Surgery Clinic at Zayed Military Hospital.
The mean age of the patients included in the study was 31.2 years (16 - 51 years). The mean weight of the patients was 88.8 Kg (49 - 120 Kg) and the mean BMI was 27.4 kg/m2 (16 - 39 Kg/m2).
The mean duration of having gynecomastia was 4.9 years (2 months - 37 years). 59 patients had primary gynecomastia since puberty (30.1%), while 137 patients had secondary gynecomastia (69.9%) (Figure 1). One hundred and one patients had history of hormonal injections (51.5%) while 95 patients denied ever having these injections as per records (48.5%). 97 of those with secondary gynecomastia had received hormonal injections (70.8% of the secondary gynecomastia). Only 4 patients of the primary gynecomastia cases had received hormonal injections. One hundred and thirteen patients (57.7%) had history of protein tablets intake while eighty three had no history of protein tablets intake (42.3%). 105 patients with 2ry gynecomastia had history of protein tablets intake (76.6% of the 2ry gynaecomastia cases).
Figure 1. The percentage of 1ry and 2ry gynaecomastia to each other in the study.
The highest incidence of gynaecomastia was found in the patients of age group of 30 - 39 years (83 cases) followed by the age group between 20 - 29 years (75 cases). These were the patients with the highest incidence of history of hormonal and proteins intake. The lowest incidence of presence of gynaecomastia in our study was found in the age group of 50 - 59 years (2 cases with no history of hormonal or protein intake) (Table 1).
Table 1. Relation of different ranges of age groups to the type of gynecomastia and hormonal and protein intake.
Age Range |
No. of Cases |
1ry gyn. |
2ry gyn. |
Hormones |
Proteins |
10 - 19 years |
9 |
7 |
2 |
0 |
1 |
20 - 29 years |
75 |
18 |
57 |
49 |
55 |
30 - 39 years |
83 |
26 |
57 |
45 |
50 |
40 - 49 years |
27 |
6 |
21 |
7 |
7 |
50 - 59 years |
2 |
2 |
0 |
0 |
0 |
|
196 |
59 |
137 |
101 |
113 |
Younger age groups used much more protein supplements than older age groups, especially individuals in 30 - 39 (49.4%) and 20 - 29 (69.3%) years of age. According to the Chi-Square test, there is a statistically significant correlation (p-value = 0.000) between the usage of protein supplements and age. This suggests that younger persons are more likely to use supplements, perhaps as a result of fitness or health-related objectives. The findings show that the age group of 20 to 39 years old has the highest frequency of protein consumption, whereas the age group of 40 years and older has limited or no intake.
Crosstab |
Count |
|
Protein supp |
Total |
|
No |
Yes |
Age |
20 - 29 years |
3 |
20 |
52 |
75 |
30 - 39 years |
9 |
33 |
41 |
83 |
less than 20 years |
0 |
8 |
1 |
9 |
40 - 49 years |
0 |
20 |
7 |
27 |
50 years and above |
0 |
2 |
0 |
2 |
Total |
12 |
83 |
101 |
196 |
Chi-Square Tests |
|
Value |
df |
Asymptotic Significance (2-sided) |
Pearson Chi-Square |
34.982a |
8 |
0.000 |
Likelihood Ratio |
37.451 |
8 |
0.000 |
N of Valid Cases |
196 |
|
|
a. 8 cells (53.3%) have expected count less than 5. The minimum expected count is 0.12. |
Symmetric Measures |
|
Value |
Approximate Significance |
Nominal by Nominal |
Phi |
0.422 |
0.000 |
Cramer’s V |
0.299 |
0.000 |
Contingency Coefficient |
0.389 |
0.000 |
Measure of Agreement |
Kappa |
.c |
|
N of Valid Cases |
196 |
|
c. Kappa statistic cannot be computed. It requires a two-way table in which the variables are of the same type. |
The Chi-square test indicates a significant correlation between the use of “Protein Supplement” and “Type” (1ry, 1ry/2ry, and 2ry). Individuals who fall into distinct “Type” groups prefer to consume protein supplements differently or not at all.
Crosstab |
Count |
|
Protein supp |
Total |
|
No |
Yes |
Type |
1ry |
1 |
51 |
7 |
59 |
1ry/2ry |
0 |
0 |
1 |
1 |
2ry |
11 |
32 |
94 |
137 |
Total |
12 |
83 |
102 |
197 |
Chi-Square Tests |
|
Value |
df |
Asymptotic Significance (2-sided) |
Pearson Chi-Square |
68.255a |
4 |
0.000 |
Likelihood Ratio |
72.687 |
4 |
0.000 |
N of Valid Cases |
197 |
|
|
a. 4 cells (44.4%) have expected count less than 5. The minimum expected count is .06. |
There is a discernible correlation between the occurrence of gynecomastia and the consumption of hormones and proteins. At the 0.05 level, the Pearson Chi-Square test (p = 0.029) indicates that there is statistically significant correlation.
Chi-Square Tests |
|
Value |
df |
Asymptotic Significance (2-sided) |
Pearson Chi-Square |
87.121a |
64 |
0.029 |
Likelihood Ratio |
90.792 |
64 |
0.015 |
N of Valid Cases |
196 |
|
|
a. 88 cells (88.9%) have expected count less than 5. The minimum expected count is 0.06. |
One hundred patients were smokers while the remaining 96 cases were not.
Fourteen patients of those included in the study had a history of previous gynecomastia surgery, while 182 patients underwent gynecomastia surgery for the first time.
The main presenting complaints of the patients were swelling in (130), and tenderness (114). The gynaecomastia was bilateral in 169 (86.2%) and unilateral in 27 (13.8%). The bilateral gynaecomastia were symmetrical in 162 and asymmetrical in 7 cases with one side bigger than the other. The unilateral gynaecomastia were more on the left side (21 cases) than on the right side (6 cases).
According to Simon’s classification, 31 patients were grade I, 89 patients were grade IIA, 46 patients were grade IIB and 23 patients were grade III. Seven patients had bilateral asymmetric gynaecomastia; 2 patients had grade I on the right side and grade IIB on the left side, 2 patients had grade IIB on the right side and IIA on the left side, one patient had grade I on the right side and grade IIA on the left side, one patient had grade IIA on the right side and grade I on the left side and one patient had grade IIA on the right side and IIB on the left side.
Regarding the incidence of bilateral and unilateral gynecomastia, our results showed no statistically significant correlation between the two (p = 0.393). Table 2 demonstrates the distribution of the sides and grades of gynaecomastia and Table 3 demonstrates the grades in the asymmetric bilateral gynaecomastia.
Table 2. Gynecomastia sides and grades.
Grade |
Bilateral 169 |
Unilateral 27 |
Total |
Symmetrical |
Asymmetrical |
Right |
Left |
I |
19 |
|
2 |
10 |
31 |
IIA |
76 |
|
3 |
10 |
89 |
IIB |
44 |
|
1 |
1 |
46 |
III |
23 |
|
0 |
0 |
23 |
Total |
162 |
7 |
6 |
21 |
|
The study employed a chi-square test of independence to investigate the distinction between the incidence of bilateral and unilateral gynecomastia. 𝜒2 χ2 (10, N = 196) = 10.559, p = 0.393, showed no statistically significant correlation between the two situations. Weak effect sizes were also suggested by symmetric metrics like Phi (0.232) and Cramer’s V (0.164), and the corresponding p-value stayed non-significant at.393. These results imply that the incidence of gynecomastia in the sample as a whole, whether bilateral or unilateral, does not differ statistically significantly.
Chi-Square Tests |
|
Value |
df |
Asymptotic Significance (2-sided) |
Pearson Chi-Square |
10.559a |
10 |
0.393 |
Likelihood Ratio |
8.550 |
10 |
0.575 |
N of Valid Cases |
196 |
|
|
a. 13 cells (72.2%) have expected count less than 5. The minimum expected count is 0.12. |
Symmetric Measures |
|
Value |
Approximate Significance |
Nominal by Nominal |
Phi |
0.232 |
0.393 |
Cramer’s V |
0.164 |
0.393 |
Contingency Coefficient |
0.226 |
0.393 |
Measure of Agreement |
Kappa |
.c |
|
N of Valid Cases |
196 |
|
c. Kappa statistic cannot be computed. It requires a two-way table in which the variables are of the same type. Table 3. The grades of the asymmetric bilateral gynecomastia. |
Bilateral Asymmetric Cases |
Right |
Left |
Case 1 |
I |
IIA |
Case 2 |
I |
IIB |
Case 3 |
1 |
IIB |
Case 4 |
IIA |
I |
Case 5 |
IIA |
IIB |
Case 6 |
IIB |
IIA |
Case 7 |
IIB |
IIA |
The surgical procedures performed were in the form of liposuction in 20 cases (10.21%), retroareolar disc excision in 36 cases (18.37%), liposuction with retroareolar disc excision in 105 cases (53.57%), Doughnut procedure in 8 cases (4.08%), Doughnut procedure with liposuction in 15 cases (7.65%) and mastectomy with nipple areaolae graft in 10 cases (5.10%). Two other cases underwent other procedures were; one case of right doughnut procedure and left liposuction with left retroareolar disc excision. The other case required only excision of an ellipse bilaterally of the inframammary redundant folds in a case of post massive weight loss. Table 4 and Figure 2 demonstrate the number and percentage of the procedures to each other. Figures 3-8 demonstrate examples of different types of procedures performed.
Table 4. The number of procedures performed and their percentage to each other.
Procedure Performed |
No. |
Percentage |
Liposuction |
20 |
10.21% |
Retroareolar Disc Excision |
36 |
18.37% |
Liposuction with Retroareolar Disc Excision |
105 |
53.57% |
Doughnut Procedure |
8 |
4.08% |
Doughtnut Procedure with Liposuction |
15 |
7.65% |
Mastectomy with nipple areolae graft |
10 |
5.10% |
Other Procedures |
2 |
1.02% |
Total |
196 |
100% |
Figure 2. Lipo: Liposuction. RAD Exci: Retroareolar Disc Excision Lipo + RAD Exci: Liposuction and Retroareolar Disc Excision Doughnut + Lipo: Doughnut and Liposuction Mastec. + NAC graft: Mastectomy and Nipple Areolae Complex graft.
Figure 3. Bilateral grade IIA gynaecomastia managed with liposuction only. Pre- and Postoperative photos.
Figure 4. Bilateral grade I gynaecomastia managed with retroareolar discs excision.
Figure 5. Bilateral grade IIA gynaecomastia managed with retroareolar discs excision. The whole gynaecomastia tissue was solely retroareolar discs with no fatty tissue aspiration.
Figure 6. Bilateral grade IIA gynaecomastia managed with liposuction breasts with retroareolar discs excision.
Figure 7. Bilateral grade IIB gynaecomastia managed with liposuction breasts with doughnut procedure.
Figure 8. Bilateral grade III gynaecomastia managed with mastectomy and nipple areolae complexes graft
The mean hospital Stay was 2.8 days (1 - 10 days) and the mean follow up period was 143.7 days. One patient stayed for 10 days had a haematoma which was evacuated surgically.
The haematoma was one of the complications found in 6 cases in the study and required surgical evacuation (3.03% of the total number of patients) but the commonest complication was recurrence which occurred in 17 cases (8.59%). Four patients developed hypertrophic scars postoperatively (2.02%), 2 patients had seromas which were aspirated in the outpatient clinic (1.01%) and another 2 patients complained of asymmetry of the sizes of the breasts postoperatively (1.01%). One patient complained of chronic left axillary nerve irritation and was referred to the Pain Clinic and received corticosteroid medication. The sum of the complications was 32 (16.16% of the total number of the patients). Table 5 and Figure 9 demonstrate the postoperative complications and their percentage. Table 6 represents the relation of each type of the surgical procedures to the complications and their incidence in each procedure.
Table 5. Postoperative complications and their percentage to the total number of patients.
Complications |
No. of Cases |
Percentage |
Recurrence |
17 |
8.59% |
Haematoma |
6 |
3.03% |
Hypertrophic Scar |
4 |
2.02% |
Seroma |
2 |
1.01% |
Asymmetry with Deformity |
2 |
1.01% |
Chronic Nerve Irritation |
1 |
0.50% |
Total |
32 |
16.16% |
Figure 9. Percentage of complications to the total number of cases.
Table 6. Relation of the type of surgical procedure to the complications and their incidence in each procedure.
Procedure Performed |
No. |
Perc. |
Rec |
Haem |
Sc |
Sero |
Asy. |
N. Irri. |
Tot Com |
Perc/ Proce |
Lipo |
20 |
10.21% |
3 |
|
|
|
|
|
3 |
15% |
RAD Exc. |
36 |
18.37% |
2 |
1 |
|
|
|
|
3 |
8.3% |
Lipo with RAD Exc. |
105 |
53.57% |
10 |
3 |
|
|
|
1 |
14 |
13.3% |
Dough. Pro. |
8 |
4.08% |
1 |
1 |
|
1 |
|
|
3 |
37.5% |
Dough. + Lipo. |
15 |
7.65% |
1 |
1 |
1 |
1 |
2 |
|
6 |
40% |
Mastec. with NAC graft |
10 |
5.10% |
|
|
3 |
|
|
|
3 |
30% |
Other Procedures |
2 |
1.02% |
|
|
|
|
|
|
0 |
0% |
Total |
196 |
100% |
17 |
6 |
4 |
2 |
2 |
1 |
32 |
|
No.: Number. Perc.: Percentage. Rec.: Recurrence. Haem: haematoma. Sc.: Hypertrophic scar. Sero: Seroma. Asy.: Asymmetry. N. Irri.: Nerve Irritation. Tot. Comp.: Total Complications. Perc/Proce: Percentage per Procedure. Lipo.: Liposuction. RAD Exc.: Rtroareolar Disc Excision. Dough. Pro.: Doughnut Procedure. Mastec. With NAC graft: Mastectomy with Nipple Areola Complex Graft.
5. Discussion
In recent years, there has been much interest among young adults going to the gymnasium for power sports and weight training to get anabolic androgenic steroids, gonadotropins, and growth hormones. These are usually in the form of injections or tablets prescribed sometimes by persons of no medical background. In male athletes, these iatrogenic drugs may suppress spermatogenesis and/or induce gynecomastia [4]. In our study more than half of the patients either had a history of hormonal injections or protein tablets intake or both together. More than two-thirds of the patients who had secondary gynecomastia had a history of hormonal injection usage or protein tablet intake. This shows the effect of high usage of these drugs on the increased incidence of the development of gynecomastia in recent years and hence the importance of patient counseling before surgery on supplement use.
Koch T. et.al reviewed the incidence of gynaecomastia in l 17,601 males between the age 0 - 80 years over a period of 20 years study and found that the highest incidence was in the age group of 16 - 20 years of 6.5/10,000 followed by incidence of 4.6/10,000 in males aged 61 to 80 years and of 4.2/10,000 in males aged 21 to 40 with less incidence in the other age groups. They found that the incidence of gynecomastia has dramatically increased over the last 20 years and attributed the increase in the incidence in the young age group to the endogenous or exogenous sex-steroid environment [5]. In our study the highest incidence of gynaecomastia was in the age groups between 20 and 39 years and they had the highest incidence of secondary gynaecomastia. This group of young adults had also the highest incidence of hormonal injections and proteins intake which confirms the effect of these medications on the development of gynaecomastia.
The main complaints of our patients in the study were an increase in the size of the breasts in 130 cases (66.3%) and tenderness in 114 cases (58.2%). This is in agreement with a study done by Costanzo et al. on medical records of 237 men aged 18 - 85 years with gynecomastia and found that the most common presenting complaints were aesthetic concerns (62.8%) and breast pain (51.2%) [6]. Our patients presented with much higher incidence of bilateral gynaecomastia than unilateral gynaecomastia (86.2% and 13.8% respectively). In some other studies unilateral gynaecomastia presented 1/3rd of their patients [7].
There are many surgical techniques and treatment protocols for correcting gynaecomastia in the literature [8]. For Simon grade I who had retroareolar disc felt, we performed retroareolar disc excision through a half circle infraareolar incision at the skin-areola junction of the nipple-areola complex. They represented 18.37% of our gynaecomastia cases. For Simon grade IIA who had excess fat only with no retroareolar disc felt liposuction was done solely through a 5 mm incision at the anterior axillary line bilaterally (10.21% of the cases). The majority of our patients had both procedures combined together by doing liposuction through a 5 mm stab wound at the anterior axillary line and at 6 o’clock at the infraareolar line before extending the later on both sides during the procedure to remove the disc. (53.57%). In cases where we performed liposuction, we used the same anterior axillary line 5 mm incisions as the site of drains extrusion.
In the literature, some studies extruded the drains through the same infraareolar incisions used for the retroareolar disc excision [1]. Trial of liposuction through anterior axillary line incisions with port site nipple sparing mastectomy avoiding incision at the infraareolar site was done by Asal et al. on 103 cases of grades I and II gynaecomastia. They used the site of the liposuction wound at the anterior axillary line to grab the retroareolar disc to outside the wound leaving point of traction on the NAC or the skin which are cut with long scissor until all adhesions released and retroareolar disc is excised. They mentioned that the benefit of this technique is to avoid scars on the anterior chest wall. They had 3 cases of haematoma, 3 cases of superficial nipple areolae necrosis, one case of nipple penetration, 12 patients had nipple retraction with deformity and 72 patients had nipple hypothesia [9]. We feel that having a small unapparent scar at the junction of the areola with the skin at the infraareolar line can avoid most of these complications. Yang et al. had another technique to avoid scars on the anterior chest wall by dissecting the subcutaneous gland in the upper quadrant of the breast through an axillary incision under endoscopy guidance. They removed the subcutaneous gland in the lower quadrant of the breast through a 3 - 5 mm auxiliary operative hole positioned at the superior lateral margin of the areola. They mentioned that it is a safe procedure but needs a learning curve [10].
Singamsetty et al. compared the aesthetic outcome of the conventional liposuction with the cross-chest liposuction in which they used the circum-areolar incision for suctioning of the lateral chest on ipsilateral side and the entire contralateral chest other than its lateral side. They found that there is no statistical difference between both techniques [11]. We feel that involving the sternal area in cross-chest liposuction could represent a more aggressive procedure in terms of morbidity, compared to traditional liposuction, producing a wider undermined area that doesn’t need to be treated.
The Doughnut procedure was performed in 4.08% of our patients and Doughnut procedure with liposuction was done in 7.65%. These procedures were used for patients mostly of Simon’s grade IIB and some patients of grade III. On the contrary, Fayed & Kholosy, who called the doughnut procedure as the round block procedure, used it in 77.1% of their gynaecomastia cases and when they combined it with liposuction, they used it in only 8.6% of their cases [12].
Filho et al. used the doughnut procedure for all their grade III gynaecomastia cases. They preferred this technique in such severe gynaecomastia cases more than other techniques as they felt that it allows the surgeon to achieve an aesthetic result while avoiding unsightly scars or serious complications [13]. Other techniques used in this grade of gynaecomastia patients are total mastectomy with free nipple areola graft and the flap technique of preservation of the nipple-areola complex on a deepithelialized dermoglandular pedicle [14]. Gusenoff et al. tried both techniques and were satisfied more with the aesthetic results of preserving the nipple-areola complex on a dermoglandular pedicle than using the total mastectomy with nipple areola graft technique [15]. On the other hand, Barone et al. showed good results with total mastectomy with nipple areola graft when they removed the excess skin in the chest region and in the axilla region as a ‘‘fish-shaped’’ pattern [16]. We used the same technique of total mastectomy with nipple areola graft using the fish-pattern incision in our grade III gynaecomastia cases with good results.
While some studies reported the postoperative complications to be as high as 36% [17], Others, on the contrary, showed incidence of as low as 4.4% [18]. Our study showed that 16.16% of our patients developed complications. This was matching with the results obtained by Tolba and Naser in their study with a complication rate of 13.4% [19].
In a retrospective review study done by Lee et al. on 98 patients who underwent reoperation because of unsatisfactory esthetic outcomes, they found that 81 of them had under-correction with residual tissue to be removed while the other 17 patients had overcorrection with excess tissues removed and required fat grafting [20]. Our results also showed that the commonest complication in our patients was recurrence with residual swelling felt in the postoperative period which required reoperation of further removal (8.59% of our total number of patients). The patients who had asymmetry with deformity represented only 1.01% of our cases.
Innocenti et al. after dividing patients into 3 groups of liposuction techniques, surgical excision techniques and combined techniques of liposuction and excision found that the combined use of surgical excision and liposuction techniques had reduction in the rate of complications compared to the other techniques [21]. Our study did not show correlation between the incidence of complications and the use of the surgical technique whether it is a combined technique or not. Still further studies are required to prove that.
6. Conclusion
Our results show a significant increase in the incidence of gynaecomastia especially in middle-aged males with the increase in the intake of hormones and proteins in this category of cases. In our study the incidence of postoperative complications had no significant relation to the type of surgical procedure performed. Still further studies are required to prove these results.
Compliance with Ethical Standards
This study was approved by Abu Dhabi Region Ethics and research Committee, Zayed Military Hospital Abu Dhabi. Reference No. 2023.09.
Surgical consent was obtained from all the patients before surgery. Consents for photography and publication were also signed by all the patients.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Acknowledgements
We thank Dr. Humariya Heena for her great contribution for this paper to see the light. We thank Mr. Domadious George Farouk for his great efforts.